Press Room thomsonreuters.com

THOMSON PHARMA ENHANCED WITH GLOBAL REGULATORY INTELLIGENCE

Web-based Resource Offers New Single Information Source for Regulatory Professionals

 

Philadelphia, PA USA-London UK — July 5, 2006 — Thomson Scientific, a business of The Thomson Corporation (NYSE: TOC; TSX: TOC), today announced a new enhancement to Thomson Pharma^SM—the drug discovery and development information solution that fulfills the information needs of professionals working at all stages of the drug development pipeline. The new Thomson Pharma Regulatory Affairs Module provides regulatory, legal and scientific information for development and registration of medicinal products and biologics.

The Regulatory Affairs Module is derived from IDRAC® , the global regulatory intelligence database that brings together information on regulatory requirements from 140 different sources, including 70 authorities. As part of the broad value-added content of Thomson Pharma , the Regulatory Affairs Module provides professionals at all stages of drug development with the information needed to make effective decisions in:

• Regulatory Intelligence : anticipate changes by surveying the global
  regulatory environment, with information on 44 countries and regions
• Regulatory Affairs : ensure products conform to regional regulatory standards,
  with expert English-language analysis of source information in local languages
• Clinical Research: access comprehensive information on initiation
  and follow-up of clinical trials, including investigational products
• Quality Assurance: view comprehensive information on
  Inspection and Enforcement, GMP, GLP and GCP
• Strategic Marketing : gain global insight on pricing and reimbursement
  regulations, control of advertising and promotion of medicinal products
• Pharmacovigilance and Risk Management : stay alert to pre- and
  post-marketing surveillance organization and ADR reporting procedures

“The Regulatory Affairs Module offers Thomson Pharma customers unparalleled access to expert documents and historical/current versions of regulations, helping them quickly embrace and keep updated with requirements and processes across countries” said Jon Brett-Harris, Executive Vice President of Pharmaceutical and Chemical markets at Thomson Scientific. “With this information, customers have a powerful global tool at their fingertips that helps them build strategies to accelerate entrance of their products into the global market.”

Additional information on this module is available at www.thomsonpharma.com

Thomson Reuters (www.thomsonreuters.com), with 2005 revenues of approximately $8.5 billion, is a global leader in providing integrated information solutions to business and professional customers. Thomson provides value-added information, software tools and applications to more than 20 million users in the fields of law, tax, accounting, financial services, higher education, reference information, corporate e-learning and assessment, scientific research and healthcare. With operational headquarters in Stamford, Conn., Thomson has approximately 40,500 employees and provides services in approximately 130 countries. The Corporation's common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Scientific is a business of Thomson Reuters. Its information solutions assist professionals at every stage of research and development—from discovery to analysis to product development and distribution. Thomson scientific information solutions can be found at www.scientific.thomson.com.

Media Contact

Allison Hagan
Thomson Reuters
Tel: +1 215-823-1881
Email